Clinical trial
Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for…
NCT00148330 · University of Sydney, Other · Completed
Key facts
| NCT number | NCT00148330 |
|---|---|
| Title | Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study |
| Official title | An Open Label Extension of the Phase II/III Clinical Trial of Intravitreal Triamcinolone on the Effects and Safety of Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment |
| Lead sponsor | University of Sydney, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Macular Oedema |
| Intervention type | Drug |
| Interventions | Triamcinolone acetate |
| Enrollment | 64 |
| Start date | May 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Sep 7, 2005 |
| Last update posted | Jun 30, 2010 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: